带状疱疹疫苗市场规模、份额、成长分析、按产品、疫苗类型、按地区 - 产业预测，2024-2031 年

2022年带状疱疹疫苗的全球市场规模为39.9亿美元，从2023年的42.9亿美元成长到2031年的77.1亿美元，预计在预测期内（2024-2031年）将以复合年增长率增长。 7.6%。

带状疱疹疫苗市场的显着成长主要是由于60岁及以上老年人患带状疱疹的风险增加以及已开发国家医疗保健政策的演变。根据 CDC 报告，大约三分之一的美国一生中会患带状疱疹，在美国、加拿大、英国和德国等国家强烈建议接种疫苗，特别是对于COVID-19 感染，这种趋势变得更加强烈。儘管成本较高，但向创新重组疫苗的转变正在推动市场前景。 2018 年 CDC 将定序优先于 Zostavax 凸显了这一趋势。随着人口老化，带状疱疹患者数量预计将增加，带状疱疹疫苗接种作为预防措施的重要性越来越受到人们的认识，从而推动了进一步的采用和市场成长。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 案例研究

带状疱疹疫苗市场规模：依产品分类

• 市场概况
• 定序
• 佐斯塔瓦克斯
• 天空之星

带状疱疹疫苗市场规模：依疫苗类型划分

• 市场概况
• 重组疫苗
• 减毒活疫苗

带状疱疹疫苗市场规模：按地区划分

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• GlaxoSmithKline（GSK）
• Merck & Co., Inc.
• Pfizer Inc.
• BioNTech SE
• SK bioscience
• GeneOne Life Science
• Curevo Inc.
• Vaccitech
• Jiangsu Recbio Technology Co., Ltd.
• Changchun BCHT Biotechnology Co.

结论和建议

Global Shingles Vaccine Market size was valued at USD 3.99 billion in 2022 and is poised to grow from USD 4.29 billion in 2023 to USD 7.71 billion by 2031, growing at a CAGR of 7.6% during the forecast period (2024-2031).

The shingles vaccine market is experiencing significant growth, primarily driven by the increased shingles risk among individuals aged 60 and older and advancements in healthcare policies across developed countries. The CDC reports that around one in three Americans will develop shingles in their lifetime, prompting strong vaccination endorsements in countries like the U.S., Canada, the U.K., and Germany, particularly heightened during the COVID-19 pandemic. The shift towards innovative recombinant vaccines, despite their higher costs, is fueling market prospects. The CDC's 2018 preference for Shingrix over Zostavax highlights this trend. With herpes zoster cases expected to rise with aging populations, the importance of shingles vaccination as a preventive measure is becoming increasingly recognized, driving further adoption and market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Shingles Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Shingles Vaccine Market Segmental Analysis

Global Shingles Vaccine Market is segmented by product, vaccine type and region. Based on product, the market is segmented into shingrix, zostavax and skyzoster. Based on vaccine type, the market is segmented into recombinant vaccine and live attenuated vaccine. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Shingles Vaccine Market

One of the primary drivers of the global shingles vaccine market is the escalating prevalence of shingles worldwide. This trend is largely attributed to the expanding aging population, which faces a heightened risk of developing shingles and experiencing associated complications. As more individuals reach an age where they are vulnerable to this viral infection, the demand for effective preventive measures grows significantly. Consequently, healthcare providers and patients alike are increasingly recognizing the importance of vaccination, thereby fueling market expansion and emphasizing the need for innovative solutions to mitigate this health concern on a global scale.

Restraints in the Global Shingles Vaccine Market

The Global Shingles Vaccine market faces significant restraints, primarily due to limited vaccine uptake in certain areas. While health authorities strongly advocate vaccination, actual participation is hindered by various factors. These include a lack of awareness about the vaccine's benefits, vaccine hesitancy among potential recipients, and apprehensions regarding possible side effects. These barriers collectively impede the market's expansion and prevent it from reaching its full potential, underscoring the necessity for enhanced educational efforts and outreach programs to address these concerns and improve vaccination rates in the affected regions.

Market Trends of the Global Shingles Vaccine Market

The Global Shingles Vaccine market is experiencing a notable upward trend, primarily fueled by the rising incidence of shingles, particularly among the aging population. As the demographic landscape shifts towards an older average age, the prevalence of herpes zoster infections is surging, prompting an urgent need for effective vaccination solutions. This growing awareness of shingles' potential complications and the effectiveness of available vaccines are further propelling market demand. Additionally, public health initiatives and recommendations from healthcare authorities aimed at increasing vaccination rates are expected to amplify growth, solidifying the shingles vaccine market's pivotal role in preventive healthcare strategies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Shingles Vaccine Market Size by Product & CAGR (2024-2031)

• Market Overview
• Shingrix
• Zostavax
• Skyzoster

Global Shingles Vaccine Market Size by Vaccine Type & CAGR (2024-2031)

• Market Overview
• Recombinant Vaccine
• Live Attenuated Vaccine

Global Shingles Vaccine Market Size & CAGR (2024-2031)

• North America (Product, Vaccine Type)
  • USA
  • Canada
• Europe (Product, Vaccine Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Vaccine Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Vaccine Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Vaccine Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• GlaxoSmithKline (GSK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioNTech SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SK bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneOne Life Science
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Curevo Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaccitech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Recbio Technology Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Changchun BCHT Biotechnology Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations